Know Labs, Inc. (NYSE:KNW) Q2 2024 Earnings Call Transcript
Operator: Greetings. Welcome to Know Labs's Second Quarter 2024 Earnings Conference Call. Please note this conference call is being recorded.
Stay updated with breaking news from Abbott Freestyle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Greetings. Welcome to Know Labs's Second Quarter 2024 Earnings Conference Call. Please note this conference call is being recorded.
Announced on April 14, the clearance allows for FreeStyle Libre 3 users to obtain real-time glucose readings on a large, easy-to-see screen directly from their back of arm sensors.
In youth with type 1 diabetes, real-time continuous glucose monitoring and insulin pump use were associated with more time in target glucose range versus intermittently scanned CGM and injections.
Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.
Improvements compared to usual care of multiple daily insulin injections and intermittently scanned CGM were larger than those seen in prior trials of hybrid closed-loop systems.